Approval · Notice of Compliance 4949 · 1995
CAPOTEN: Notice of Compliance 4949
Issued July 31, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4949
- Date
- July 31, 1995
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use in post-mi
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAPOTEN | Not yet assigned | — |